Mitchell Stephen Ray
CIK 0001802653
Director
Filings
9
Latest May 20, 2026
Issuers covered
1
Showing
9 of 9
Page 1
Track record
4 of 4 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 4 | 50% | -0.7% | -0.5% | +22.1% | -23.7% |
| 90 days | 4 | 50% | +5.6% | +2.4% | +28.1% | -10.6% |
| 180 days | 4 | 50% | -1.4% | +3.0% | +38.0% | -49.7% |
| 365 days | 3 | 100% | +19.4% | +14.7% | +29.8% | +13.8% |
Issuers
Companies where Mitchell Stephen Ray has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| VNDA | Vanda Pharmaceuticals Inc. | 9 | May 20, 2026 |
All filings
9 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|